In summary, we have presented for the first time that increased FVII expression by tumor cells correlates with progression of HCC and acts as a poor prognostic factor after surgery and demonstrated that FVII/PAR2 through p-ERK1/2 signaling is involved in HCC progression. The gene discussed is MAPK3; the disease is neoplasm.